Uso de xantana e ciclodextrina como sistema de liberação controlada de cloreto de cetilpiridínio
Loading...
Date
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Universidade Federal de Juiz de Fora (UFJF)
Abstract
New formulations of controlled release systems (SLCs) have reached the market
demonstrating progress in this field. SLCs can be defined as technologies designed to achieve
greater drug efficiency and reduced adverse effects. From this perspective, the present study
tested cetylpyridinium chloride (CCP), a cationic surfactant, with broad-spectrum
antimicrobial activity against bacteria, including Staphylococcus aureus and Streptococcus
mutans. At the appropriate concentration, CCP is widely used as an antiseptic, due to its low
toxicity and non-irritation of mucous membranes. CCP was combined with xanthan (XANT)
and modified cyclodextrins, hydroxypropyl-β-cyclodextine (HPβCD) and poly-β-cyclodextrin
(pCD), in order to develop controlled release systems for this compound, since XANT
presents ability to spontaneously associate with cationic compounds and cyclodextrins (CDs)
ability to incorporate guest molecules. The samples were characterized in the solid state by
Fourier transform infrared spectroscopy (FTIR) and thermal analyzes (TGA and DTA). The
interactions between CCP, CDs and XANT were characterized in solution, by dynamic light
scattering (DLS), conductivity and zeta potential (ZP) measurements. The interaction of CCP
with XANT was also investigated by stationary rheology at 25 oC. To understand the
thermodynamic complexation parameters, the interactions between the compounds were
characterized by isothermal titration calorimetry. The antimicrobial action of the respective
complexes formed by CCP with HPβCD (CCP/HPβCD), with pCD (CCP/pCD) and with
XANT (CCP/XANT) was evaluated through biological studies against four strains of
Staphylococcus aureus and one strain of Streptococcus mutans. The results obtained
demonstrated spontaneous formation of CCP inclusion complexes in modified βCDs and the
CCP complex with XANT. Regarding biological activity, it was observed that in the presence
of HPβCD and pCD there was a reduction in MIC and LD50 compared to S. aureus strains,
suggesting that the complexes showed promise for use in controlled CCP release systems. S.
mutans inhibition/adhesion assays showed that the CCP/XANT complex was the one that
showed the greatest inhibition of biofilm formation.
Description
Citation
Endorsement
Review
Supplemented By
Referenced By
Creative Commons license
Except where otherwise noted, this item's license is described as Acesso Aberto

